INTERNATIONAL SCHOOL OF PRECISION MEDICINE AND LABORATORY MEDICINE. 4THCOURSE ALZHEIMER’S DISEASE IN THE ERA OF PRECISION MEDICINE: FROM SCREENING

• MARCELLO CIACCIO· MEDICO CHIRURGO

• LUISA AGNELLO· RELATORE
• FEDERICA AGOSTA· RELATORE
• ALBERTO BENUSSI· RELATORE
• VALENTINA BESSI· RELATORE
• MARCO BOZZALI· RELATORE
• FILIPPO BRIGHINA· RELATORE
• ANNACHIARA CAGNIN· RELATORE
• LORENZO GAETANI· RELATORE
• CESARE GAGLIARDO· RELATORE
• MARCELLO MOCCIA· RELATORE
• ALESSANDRO PADOVANI· RELATORE
• TOMMASO PICCOLI· RELATORE
• ANDREA PILOTTO· RELATORE
• GIUSEPPE SALEMI· MODERATORE
• FRANCESCO SALVATORE· RELATORE
• MARINA TURCO· MODERATORE
• ANTONINO TUTTOLOMONDO· RELATORE
• LAURA VERNUCCIO· RELATORE
• MARTINA ZANINOTTO· RELATORE
• MARIO ZAPPIA· RELATORE

Ragione sociale

BIOMEDIA SRL

Stato accreditamento

STANDARD - 2° rinnovo

Professionali

Alzheimer’s disease (ad) remains one of the most pressing public health challenges of our time, with rising prevalence due to global population aging and no definitive cure currently available. Traditionally considered a uniform clinical entity, ad is now recognized as a biologically heterogeneous condition with diverse trajectories, underpinned by complex interactions between genetic, molecular, environmental, and lifestyle factors. The era of precision medicine has opened a new frontier in the fight against alzheimer’s disease. By shifting from a one-size-fits-all approach to a model that considers individual variability in genes, biomarkers, and disease progression, precision medicine offers the promise of earlier diagnosis, more accurate risk stratification, and tailored therapeutic strategies.

#2Linee guida - protocolli - procedure

Area: Obiettivi formativi tecnico-professionali

Partecipanti max

120

Verifica presenza

Firma Di Presenza

Verifica apprendimento

Questionario A Risposta Multipla Online